Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Addex Therapeutics Ltd

Addex Therapeutics Ltd (ADXN.SW) Stock Overview

Explore Addex Therapeutics Ltd’s financial performance, market position, analyst ratings, and future outlook.

ADXN.SW●SIX
HealthcareBiotechnology
CHF0.04
CHF0.002(3.92%)
Swiss Market is Open · 16:25

Addex Therapeutics Ltd (ADXN.SW)

Meyka AI Score

Z

Key Financials

Market Cap6.3M
P/E Ratio-0.75
EPS (TTM)$-0.06
ROE-1.31%
Fundamental Analysis

AI Price Forecasts

1 Month$0.04
3 Months$0.04
1 Year Target$0.02

ADXN.SW Stock Analysis & Investment Overview (SIX)

Our AI-powered analysis of Addex Therapeutics Ltd (SIX: ADXN.SW) gives investors deep insight into how the stock performs on the SIX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Addex Therapeutics Ltd's SIX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ADXN.SW on the SIX shows an RSI of 51.13, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.02 for the SIX listing.

Key metrics behind Addex Therapeutics Ltd's SIX-traded stock include a P/E ratio of -0.75 and a market capitalization of 6.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ADXN.SW on the SIX.

Price Performance (SIX: ADXN.SW)

1-Day Change
1.47%
5-Day Change
N/A
1-Month Change
3.50%
3-Month Change
-12.66%
6-Month Change
-14.81%
Year-to-Date (YTD) Change
-21.89%
1-Year Change
-29.35%
3-Year Change
-51.29%
5-Year Change
-97.29%
All-Time (Max) Change
-99.94%

Contact Information

https://www.addextherapeutics.com
41 22 884 1555
Chemin des Mines, 9, Geneva, GE, 1202

Company Facts

30 Employees
IPO DateMay 22, 2007
CountryCH
Actively Trading

Frequently Asked Questions